Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized crossover study of cyclosporine A effects on OATP1B biomarkers and probe drugs
jRCTs031200012Completed
- Sponsor
- Research Collaboration Consortium
- Start
- Jun 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of cyclosporine (2 arms), sponsored by Research Collaboration Consortium. Primary endpoints: Pharmacokinetics of endogenous substrates with cyclosporine A, Pharmacokinetics of pitavastatin, rosuvastatin, valsartan, and cyclosporine A and 1 more. Started Jun 2020; status: completed.
02
Drugs
cyclosporine
Beyond the preview
Go deeper on jRCTs031200012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200012.